XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 116 $ 83
Accounts receivable, net 868 797
Accrued unbilled revenues 605 764
Inventories 492 610
Regulatory assets 422 424
Derivative instruments 28 44
Prepaid taxes 63 68
Prepayments and other 188 183
Total current assets 2,782 2,973
Property, plant and equipment, net 34,679 34,329
Other assets    
Nuclear decommissioning fund and other investments 2,404 2,397
Regulatory assets 2,965 3,005
Derivative instruments 49 48
Other 280 278
Total other assets 5,698 5,728
Total assets 43,159 43,030
Current liabilities    
Current portion of long-term debt 457 457
Short-term debt 1,025 814
Accounts payable 1,027 1,243
Regulatory liabilities 270 239
Taxes accrued 544 448
Accrued interest 147 174
Dividends payable 193 183
Derivative instruments 30 29
Other 429 501
Total current liabilities 4,122 4,088
Deferred credits and other liabilities    
Deferred income taxes 3,905 3,845
Deferred investment tax credits 57 58
Regulatory liabilities 5,141 5,083
Asset retirement obligations 2,504 2,475
Derivative instruments 120 126
Customer advances 200 193
Pension and employee benefit obligations 884 1,042
Other 143 145
Total deferred credits and other liabilities 12,954 12,967
Commitments and contingencies
Capitalization    
Long-term debt 14,522 14,520
Common stock — 1,000,000,000 shares authorized of $2.50 par value; 508,661,859 and 507,762,881 shares outstanding at March 31, 2018 and Dec. 31, 2017, respectively 1,272 1,269
Additional paid in capital 5,903 5,898
Retained earnings 4,510 4,413
Accumulated other comprehensive loss (124) (125)
Total common stockholders’ equity 11,561 11,455
Total liabilities and equity $ 43,159 $ 43,030